KLRS
#4131
Kalaris Therapeutics, Inc. - Common Stock
2.2 3 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.33%
Variación mensual
-33.43%
Variación en los últimos 6 meses
-61.81%
Cambio anual
-78.20%
Cierres anteriores
2.2 6
Open
2.2 7
Mínimo
2.2 0
Máximo
2.3 0
Financials
- Market Capitalization 53.09 M
- Employee 20
- Founded 2019
- CEO N/A
- Website www.kalaristx.com
- Headquarter Delaware, United States
- FIGI BBG00P80SH34
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4124 |  ALDX Aldeyra Therapeutics, Inc. - Common Stock | 0.90 USD | -1.10% | -1.10% | -37.93% | -83.15% | 54.29 M USD | ||
| 4129 |  GUTS Fractyl Health, Inc. - Common Stock | 4.03 USD | -8.62% | -11.04% | +571.67% | +192.03% | 53.46 M USD | ||
| 4134 |  ELOX Eloxx Pharmaceuticals, Inc. | 13.00 USD | -6.41% | -14.87% | -19.75% | +30.00% | 52.47 M USD | ||
| 4136 |  INKT MiNK Therapeutics, Inc. - Common Stock | 10.27 USD | -2.47% | -11.69% | -10.38% | -6.64% | 52.41 M USD |